Oyster Point Pharma, Inc. Comprehensive Income
Oyster Point Pharma, Inc. reported Comprehensive Income of -$36.75 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Income Statement
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2022-11-10
- Oyster Point Pharma, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-09-30 was -$36.75M.
- Oyster Point Pharma, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-06-30 was -$49.94M.
- Oyster Point Pharma, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-09-30 was -$17.67M.
- Oyster Point Pharma, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-06-30 was -$22.02M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month |
|---|---|---|---|
| 2022-09-30 | -$36.75M 10-Q · filed 2022-11-10 | -$86.69M derived: sum of 2 quarters · filed 2022-11-10 | -$134.58M 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$49.94M 10-Q · filed 2022-08-11 | -$97.83M 10-Q · filed 2022-08-11 | |
| 2021-09-30 | -$17.67M 10-Q · filed 2022-11-10 | -$39.69M derived: sum of 2 quarters · filed 2022-11-10 | -$58.59M 10-Q · filed 2022-11-10 |
| 2021-06-30 | -$22.02M 10-Q · filed 2022-08-11 | -$40.92M 10-Q · filed 2022-08-11 | |
| 2021-03-31 | -$18.91M 10-Q · filed 2021-05-06 | ||
| 2020-09-30 | -$16.30M 10-Q · filed 2021-11-04 | -$31.77M derived: sum of 2 quarters · filed 2021-11-04 | -$48.29M 10-Q · filed 2021-11-04 |
| 2020-06-30 | -$15.46M 10-Q · filed 2021-08-05 | -$31.98M 10-Q · filed 2021-08-05 | |
| 2020-03-31 | -$16.52M 10-Q · filed 2021-05-06 | ||
| 2019-09-30 | -$11.50M 10-Q · filed 2020-11-05 | -$22.23M derived: sum of 2 quarters · filed 2020-11-05 | -$25.99M 10-Q · filed 2020-11-05 |
| 2019-06-30 | -$10.73M 10-Q · filed 2020-08-05 | -$14.49M 10-Q · filed 2020-08-05 | |
| 2019-03-31 | -$3.76M 10-Q · filed 2020-05-11 |